Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Injection for Knee Osteoarthritis
NCT03694821Phase 4Terminated
- Sponsor
- UConn Health
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in osteoarthritis (OA) (3 arms), sponsored by UConn Health. Primary endpoint: Visual Analogue Pain Scale at 3 months. Started Jul 2018; status: terminated.
02
Drugs
ketorolac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03694821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694821.